This is a Validated Antibody Database (VAD) review about rat carnitine deficiency associated gene expressed in ventricle 1, based on 4 published articles (read how Labome selects the articles), using carnitine deficiency associated gene expressed in ventricle 1 antibody in all methods. It is aimed to help Labome visitors find the most suited carnitine deficiency associated gene expressed in ventricle 1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
carnitine deficiency associated gene expressed in ventricle 1 synonym: Cdv-1; Cdv1; intraflagellar transport protein 81 homolog; carnitine deficiency-associated gene expressed in ventricle 1; carnitine deficiency-associated protein expressed in ventricle 1; intraflagellar transport 81 homolog
Proteintech Group
| rabbit polyclonal |
| Proteintech Group carnitine deficiency associated gene expressed in ventricle 1 antibody (Proteintech, 11744-1-AP) was used in immunocytochemistry on human samples at 1:50 (fig 3B). Methods Cell Biol (2016) ncbi |
| rabbit polyclonal |
| In order to suggest that IFT52 mutations result in a ciliopathy with primary effects on the skeleton, Proteintech Group carnitine deficiency associated gene expressed in ventricle 1 antibody (ProteinTech, 11744-1-AP) was used in western blot on human samples at 1:1000 (fig 4b). Hum Mol Genet (2016) ncbi |
| rabbit polyclonal |
| In order to study primary ciliogenesis in polarized epithelial cells, Proteintech Group carnitine deficiency associated gene expressed in ventricle 1 antibody (Proteintech, 11744-1-AP) was used in immunocytochemistry on dog samples at 1:100 (fig s1c). J Cell Biol (2016) ncbi |
| rabbit polyclonal |
| Proteintech Group carnitine deficiency associated gene expressed in ventricle 1 antibody (Proteintech, 11744-1-AP) was used in western blot on human samples at 1:1000 (fig 4). Nat Cell Biol (2015) ncbi |
Articles Reviewed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments
